Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
52 Cards in this Set
- Front
- Back
Diabetes goals for treatment?
|
FPG= 90-130
2 hour post gpandial PG<180 Glcosylated Hg<7.0% |
|
Aspart insulin?
|
Rapid acting, used for premeal, monomeric, onset 5-15 min
|
|
Lispro Insulin?
|
Rapid acting, used for premeal, monomeric, onset 5-15 min
|
|
Glulisine Insulin?
|
Rapid acting, used for premeal, monomeric, onset 5-15 min
|
|
Regular insulin?
|
Hexamer with zink, used for meals, onset 30-60 min
|
|
NPH insulin?
|
Intermediate acting, conjugated with protamine peptide, used for basal insulin
|
|
Lente insulin?
|
Intermediate acting, conjugated with protamine peptide, used for basal insulin
|
|
Glargine insulin?
|
Long acting, AA substitute, ppt at body pH, no peak
|
|
Detmir insulin?
|
Long acting, fatty acid side chain binds to albumin, no peak
|
|
Adverse reactions of Insulin replacement therapy?
|
Injection site lipodystrophy
|
|
Conventional Insulin therapy?
|
Two injections with regular and NPH, there is a risk of htpoglycemia, and dawn phenomenon(hyperglycemia)
|
|
Intensive/standard therapy?
|
Premeal and long acting, decreases diabetes complications, more difficult to comply, more expensive
|
|
Chlorpropamide?
|
first generation Sulfonylurea for type 2 diabetes
|
|
Tolbutamide?
|
first generation Sulfonylurea for type 2 diabetes
|
|
Glimepiride?
|
second generation Sulfonylurea for type 2 diabetes
|
|
glipizide?
|
first generation Sulfonylurea for type 2 diabetes, short acting, drug of choice for elderly with renal failure
|
|
Glypuride?
|
first generation Sulfonylurea for type 2 diabetes
|
|
Sulfonylurea MOA?
|
inhibits beta-cell K+ channels and increases insuline secretion
|
|
Sulfonylurea on Plasma glucose?
|
Lowers fasting plasma glucose, not post-prandial
|
|
Sulfonylurea Side Effects?
|
Hypoglycemia, weight gain
|
|
Sulfonylurea CI?
|
Pregnancy, renal, liver failure, sulfa allergies, type 1, elderly except Glipizide
|
|
Sulfonylurea is indicated for?
|
Diabetes for less than 10 years, not overweight, can still secrete insulin
|
|
Repaglinide?
|
Meglitinide for diabetes type 2
|
|
Nateglinide?
|
Meglitinide for diabetes type 2
|
|
Meglitinides MOA?
|
Acts on K+ channels on beta-cells, different spot as Sulfonylurea
|
|
Meglitinides effects on plasma glucose?
|
decreases postprandial glucose
|
|
Meglitinides Indicated for?
|
people with sulfa allergies and cannot take sulfonylureas
|
|
Meglitinides CI?
|
Pregnant and liver disease
|
|
Metformin(biguanides) MOA?
|
Activates AMPK which decreases gluconeogenesis and glycolysis, increase glucose utilization and decreas insulin resistance
|
|
Metformin effects on plasma glucose?
|
Decreases FPG
|
|
Metformin Indications?
|
No weight gain or hypoglycemia, improved lipid profile
|
|
Metformin ADRs?
|
GI(take with food), decrease B-12 absorption, lactic acidosis
|
|
Metformin contraindications?
|
PRegnars, elderly, renal and liver disease, CHF, shock, iodinized contrast agents
|
|
Pioglitazone and Rosiglitazone?
|
Thiazolidediones
|
|
Thiazolidediones MOA?
|
PPAR-gama(transcription factors) agonist, causes increase GLUT4, increase adiponectin which increases insulin sensitivity
|
|
Thiazolidediones Effects on Plasm Glucose?
|
Decreases FPG, decreases triglycerides
|
|
Thiazolidediones adverse effects?
|
Weight gain, fluid retention, CHF
|
|
Thiazolidediones Contraindications?
|
Liver disease, CHF, Pregnancy
|
|
Acarbose and Miglitol
|
alpha-glucosidase inhibitors
|
|
alpha-glucosidase inhibitors MOA
|
inhibits brush boarder enzyme and decreases absorption of glucose
|
|
alpha-glucosidase inhibitors effects on plasma glucose?
|
decreases post prandial glucose
|
|
alpha-glucosidase inhibitors CI?
|
IBD, ulcers, obstruction
|
|
Pramlinitide MOA?
|
Amylin mimetic, decreases postprandial glucagon....
|
|
Pramlinitide Indication?
|
Weight loss, decrease postprandial glucose
|
|
Pramlinitide ARDs?
|
Nausea, hypoglycemia, injected side effects
|
|
Exenatide MOA?
|
GLP-1 analog, potentiates glucose mediated insulin secretion...
|
|
Exanatide Indications?
|
Decrease post prandial glucose and weiht loss
|
|
Sitagliptin MOA?
|
DPP-IV inhibitor, DPP-IV inactivates GLP-1
|
|
Sitagliptin effects of plasma glucose?
|
decreases post-prandial and FPG
|
|
First DOC for Diabetes type 2?
|
Metformin, then add Sulfonylureas or thiazolinedione, then try adding insulin
|
|
Diabetes type 2 teatments that lowers FPG?
|
Metformin, Sulfonylureas, Thiazolidinediones
|
|
Diabetes type 2 teatments that lowers post-prandial glucose?
|
Meglitinides, Alpha-glucosidase inhibitors, Pramlintide
|